Sanofi, Schaeffler share price in focus as companies to consider dividend today
Sanofi India, Schaeffler India share prices will remain in focus on Thursday as will declare dividend today. The meeting of ...
Sanofi India share price rises up to 6% post Q4 results, Dividend announcements
Sanofi India share price gained up to 6% in morning trades on Friday post Q4 results announced by the company after the ...
Stocks to Watch Today: HCL Tech, Sanofi India, KSB, PB Fintech, Transrail Lighting, Tata Power, Granules India, Kernex in focus on 28 February
Stocks like Schaeffler India, GE Power India, Coal India, Servotech Renewable Power System, Chemplast Sanmar, Rail Vikas ...
Novavax Q4 Earnings Review: Long-Term Downsizing Plan Suggests Sell Rating
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
A Boon For Investors! Pharma Giant Recommends Massive Dividend of Rs 117; A Solid Move For Shareholder Value?
With a market valuation of Rs 11,574.76 Cr, Sanofi Indias shares ended Fridays trading session on the BSE 0.58% higher at Rs ...
Stock Market Live Updates: Sensex Lowest Level Since June 2024, Nifty Struggles At 22,100; All Indices In Red
The equity market witnessed a sharp decline today, with both benchmark indices dropping over 1%. By noon, the Sensex tumbled ...
Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value
Novavax Inc (NASDAQ:NVAX) reported fourth-quarter 2024 sales of $88.31 million, compared to $291 million a year, beating the ...
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California made a bold announcement that it would manufacture a state-branded, low-cost insulin. Drug manufacturers, insurers, economists and diabetics took notice. It had the potential to disrupt the ...
pharmaphorum5d
Sanofi says new drugs can add €10bn to sales by 2030
and also after the France-headquartered group issued a surprise rise in R&D spending accompanied by a profit warning in October that saw its share price come under pressure. Sanofi CEO Paul Hudson ...